Brandon Smith is a partner at Childers, Schlueter & Smith (CSS) in Atlanta, Georgia. He represents individuals nationwide in pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
Two recent appellate decisions reached different outcomes in NEC baby formula litigation, highlighting how appeals continue to shape lawsuits involving Abbott, Mead Johnson, and claims that cow's milk-based formula increased the risk of necrotizing enterocolitis in premature infants.
A new Georgia Supreme Court decision could influence medical malpractice and wrongful death litigation for years by reaffirming important jury trial protections and limiting how damages caps apply.
The FDA has expanded Dupixent's use to additional pediatric patients while continuing to review reports of cutaneous T-cell lymphoma. Researchers, regulators, and attorneys are closely watching developments involving the widely prescribed medication.
The appellate ruling rejected key defense arguments from Abbott Laboratories and could influence future NEC baby formula lawsuits involving premature infants and cow’s milk-based formula products.
A recent Illinois NEC baby formula verdict is adding to ongoing litigation involving claims that certain preterm formulas increased the risk of NEC in premature infants.